Diagnos Inc.
ADK.V
TSX
Weiss Ratings | ADK.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Very Weak | |||
Risk Index | Weak | |||
Risk Grade | D | |||
Reward Grade | E | |||
Rating Factors | ADK.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Index | -- | |||
Growth Index | Weak | |||
Efficiency Index | Very Weak | |||
Solvency Index | Weak | |||
Total Return Index | Weak | |||
Volatility Index | Weak | |||
Beta / Standard Deviation | ADK.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Beta | 0.08 | |||
Price History | ADK.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | 4.62% | |||
30-Day Total Return | -6.85% | |||
60-Day Total Return | 3.03% | |||
90-Day Total Return | 6.25% | |||
Year to Date Total Return | 13.33% | |||
1-Year Total Return | 28.30% | |||
2-Year Total Return | -5.56% | |||
3-Year Total Return | 38.78% | |||
5-Year Total Return | 44.68% | |||
52-Week High % Change | -27.33% | |||
52-Week Low % Change | 35.87% | |||
Price | ADK.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
52-Week High Price | $0.43 | |||
52-Week Low Price | $0.23 | |||
52-Week Low Price (Date) | Mar 21, 2024 | |||
52-Week High Price (Date) | Aug 20, 2024 | |||
Valuation | ADK.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Market Cap | 22.13M | |||
Enterprise Value | 22.45M | |||
Price/Earnings (TTM) | -- | |||
Earnings Per Share (TTM) | -0.03 | |||
Earnings Per Share Growth | 4.76% | |||
Price/Earnings To Growth | -- | |||
Price/Sales (TTM) | 347.22 | |||
Price/Book (Q) | -89.29 | |||
Enterprise Value/Revenue (TTM) | 240.92 | |||
Price | $0.34 | |||
Enterprise Value/EBITDA (TTM) | -9.97 | |||
Enterprise Value/EBIT | -9.65 | |||
Market Cap Category | Nano Cap | |||
Dividends and Shares | ADK.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Shares Outstanding | 93.73M | |||
Dividend Yield | -- | |||
Div. Per Share (Most Recent) | -- | |||
Dividend Per Share (TTM) | -- | |||
Payout Ratio (TTM) | -- | |||
Dividend Per Share (Most Recent) | -- | |||
Company Info | ADK.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Phone Number | 450 678 8882 | |||
Address | 7005 Taschereau Boulevard Brossard, QC J4Z 1A7 | |||
Website | www.diagnos.com | |||
Country | Canada | |||
Year Founded | 1998 | |||
Profitability | ADK.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Operating Margin (TTM) | -2,497.85% | |||
Profit Margin | -2,937.44% | |||
Management Effectiveness | ADK.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Return on Assets | -101.88% | |||
Return on Equity | -- | |||
Income Statement | ADK.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Revenue (TTM) | 93.20K | |||
Total Revenue (TTM) | 93.20K | |||
Revenue Per Share | $0.00 | |||
Gross Profit (TTM) | -635.40K | |||
EBITDA (TTM) | -2.25M | |||
EBIT (TTM) | -2.33M | |||
Net Income (TTM) | -2.74M | |||
Net Income Avl. to Common (TTM) | -2.74M | |||
Total Revenue Growth (Q YOY) | -51.44% | |||
Earnings Growth (Q YOY) | -45.57% | |||
EPS Diluted (TTM) | -0.03 | |||
EPS Diluted Growth (Q YOY) | -12.20% | |||
Balance Sheet | ADK.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Cash and Short-Term Inv. (Q) | 1.96M | |||
Cash Per Share (Q) | $0.02 | |||
Total Current Assets (Q) | 2.10M | |||
Total Preferred Equity (Q) | -- | |||
Total Equity (Q) | -331.70K | |||
Current Ratio (Q) | 0.952 | |||
Book Value Per Share (Q) | $0.00 | |||
Total Assets (Q) | 2.22M | |||
Total Current Liabilities (Q) | 2.21M | |||
Total Debt (Q) | 2.28M | |||
Total Liabilities (Q) | 2.55M | |||
Total Common Equity (Q) | -331.70K | |||
Cash Flow | ADK.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Cash from Investing (TTM) | -1.86M | |||
Cash from Financing (TTM) | 3.97M | |||
Net Change in Cash (TTM) | -16.40K | |||
Levered Free Cash Flow (TTM) | -1.54M | |||
Cash from Operations (TTM) | -2.12M | |||